Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avatrombopag”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Post-approval studies (Phase 4)Looking for participantsNCT07133659
What this trial is testing

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Who this might be right for
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University 25
Not applicableUnknownNCT05433922
What this trial is testing

Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly

Who this might be right for
Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 80
Testing effectiveness (Phase 2)UnknownNCT06001567
What this trial is testing

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Who this might be right for
ThrombocytopeniaHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Not applicableStudy completedNCT04609891
What this trial is testing

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Who this might be right for
Thrombocytopenia
Anhui Provincial Cancer Hospital 74
Post-approval studies (Phase 4)UnknownNCT04915287
What this trial is testing

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Who this might be right for
Thrombocytopenia; DrugsChronic Liver Disease
Chinese PLA General Hospital 476
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915
What this trial is testing

The Holistic Study

Who this might be right for
Thrombocytopenia Purpura
Ostfold Hospital Trust 220
Post-approval studies (Phase 4)UnknownNCT05382013
What this trial is testing

Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

Who this might be right for
ThrombocytopeniaHepatitis B, ChronicAcute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University 60
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Large-scale testing (Phase 3)Study completedNCT03471078
What this trial is testing

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sobi, Inc. 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT05772546
What this trial is testing

Avatrombopag vs. Placebo for CIT in GI Malignancies

Who this might be right for
Gastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia
Hanny Al-Samkari, MD 60
Not applicableUnknownNCT05087459
What this trial is testing

Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma

Who this might be right for
Thrombocytopenia
Shanghai Zhongshan Hospital 141
Testing effectiveness (Phase 2)WithdrawnNCT04312789
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Platelet Disorder
Ayman Saad
Large-scale testing (Phase 3)Study completedNCT01972529
What this trial is testing

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Who this might be right for
Thrombocytopenia Associated With Liver Disease
Eisai Inc. 231
Not applicableUnknownNCT04949009
What this trial is testing

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Shandong University 400
Not applicableUnknownNCT04913597
What this trial is testing

Switching Avatrombopag and Rh-TPO in ITP

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)Study completedNCT01976104
What this trial is testing

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Who this might be right for
Thrombocytopenia Associated With Liver Disease
Eisai Inc. 204
Testing effectiveness (Phase 2)WithdrawnNCT04437953
What this trial is testing

Avatrombopag for Thrombocytopenia in People With Cancer

Who this might be right for
ThrombocytopeniaCancerLiver Diseases
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04797182
What this trial is testing

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Who this might be right for
ThrombocytopeniaCytarabine Causing Adverse Effects in Therapeutic UseLymphoma
Sun Yat-sen University 46
Load More Results